01/09/2026
Progenesis is sponsoring SWES 2026🌵
Stop by Booth #32 to explore our latest research, genetic testing solutions, and software innovations.
We can’t wait to connect with you in person!
Progenesis offers the latest technology in embryo testing for IVF. Our goal is to help solve infertility and inherited disorders through genetic testing.
4150 Regents Park Row, Ste 245
La Jolla, CA
92037
| Monday | 9am - 9pm |
| Tuesday | 8am - 9pm |
| Wednesday | 8am - 9pm |
| Thursday | 8am - 9pm |
| Friday | 8am - 9pm |
| Saturday | 8am - 9pm |
Be the first to know and let us send you an email when Progenesis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Progenesis:
The story of Progenesis begins with a team of innovative scientists and entrepreneurs, who are passionate about helping couples start healthy families. Our journey started in 2013 as the first research group to optimize Next Generation Sequencing (NGS) for PGT-A testing, a work that led to the launch of Previda®, the first NGS test in the US.
Since 2015, we launched Previda®-DX, the first NGS-based test for structural rearrangements (PGT-SR) and monogenic disorders (PGT-M), and Avenir®, a carrier screening test covering 500 disorders.
In 2016, Revela® software was launched. Designed by the best minds in IVF, Revela® has revolutionized the way clinics handle their PGT-A needs. Armed with artificial intelligence, our portal is designed to improve clinical outcomes.
Today, Progenesis is one of the leading PGT-A companies in the US. Our success lies in our team of compassionate individuals driven by passion and innovation.